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Abstract
Background: The aim of this study was to characterize the presence and roles of CXCL12,
CXCL8, CXCL1, and HGF in five human uveal melanoma cell lines, using different methods, in
order to ascertain their significance in this disease.
Methods: Five human uveal melanoma cell lines (92.1, SP6.5, MKT-BR, OCM-1, and UW-1) of
known proliferative, invasive, and metastatic potential were used in this experiment. A migration
assay was used in order to assess the responsiveness of each cell line towards the four chosen
chemotactic factors. Immunohistochemistry was then performed for all five cell lines (cytospins)
using antibodies directed toward CXCL1, CXCL8 and their receptors CXCR2 and CXCR1
respectively. Quantitative real-time PCR was then performed on all five cell lines in order to
establish the presence of these four chemotactic factors.
Results: All five human uveal melanoma cell lines migrated towards the four chosen chemotactic
factors at a level greater than that of the negative control. Chemokines CXCL1 and CXCL8
resulted in the greatest number of migrating cells in all five of our cell lines. Immunohistochemistry
confirmed the expression of CXCL1, CXCL8, and their receptors CXCR2 and CXCR1 in all five
of the cell lines. Quantitative real-time PCR results established expression of CXCL8, CXCL1, and
HGF in all 5 cell lines tested. CXCL1 and CXCL8 are highly expressed in SP6.5 and UW-1. None
of the five cell lines expressed any detectable levels of CXCL12.
Conclusion:  The migratory ability of the 5 human uveal melanoma cell lines was positively
influenced by the four chemotactic factors tested, namely CXCL12, CXCL8, CXCL1, and HGF.
Self-expression of chemotactic factors CXCL8, CXCL1, and HGF may indicate an autocrine
system, which perhaps contributes to the cells' metastatic ability in vivo.
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Background
Uveal melanoma is the most common primary intra-ocu-
lar tumor in adults. Despite advances in diagnosis and
local treatment of patients over the last 30 years, the mor-
tality rate has remained constant, with 30 to 50% of
patients developing metastatic disease [1]. Due to the lack
of lymphatics in the eye, metastasis of uveal melanoma
occurs via hematogenous dissemination, with most
metastases developing in the liver [2].
It is now well described and understood that chemo-
attractive cytokines referred to as chemokines play a
number of functional roles in tumor biology [3]. Chem-
okines are known to mediate leukocyte trafficking, hae-
matopoiesis, inflammation during infection, chronic
inflammatory conditions, angiogenesis, and tumorigene-
sis [3]. Recent evidence has demonstrated that chemok-
ines play a critical role in cellular transformation, tumor
growth, homing, and metastasis [4].
Metastatic disease is typically characterized by initial cell
transformation within the primary tumor site followed by
angiogenesis, facilitating nutrient delivery to the newly
transformed cells. Later events include cellular prolifera-
tion and detachment from the local extracellular matrix,
followed by cell migration and intravasation into the
newly formed angiogenic processes [5]. Interactions
between tumor cells and the local environment contain-
ing secreted chemokines are thought to be important in a
number of tumorigenic processes including the initial cell
migration and intravasation; therefore, in vitro studies
investigating these interactions are important to further
gain an understanding of the steps involved in the meta-
static cascade.
Members of the CXC chemokine family have been shown
to be involved in malignant melanoma cell growth and
invasion in an autocrine dependent manner [6]. Chronic
over-expression of CXCL1 and CXCL8 in cutaneous
melanoma cell lines leads to angiogenesis and cell prim-
ing to disseminate from the primary site [7]. Migratory
stimulation of uveal melanoma cell lines (SOM196B,
SOM157d, SOM267, SOM269) with CXCL1 has been pre-
viously shown [8]. Migratory capability of the 5 human
uveal melanoma cell lines (92.1, SP6.5, MKT-BR, OCM-1,
UW-1) has not yet been established, nor has the auto-
expression of these factors within the cells themselves.
Due to the extreme differential metastatic abilility of uveal
melanoma cell lines 92.1, SP6.5, MKT-BR, OCM-1, UW-1
it is important to investigate how these specific cell lines
respond and differentially express these chemo-attract-
ants. Expression of chemokines in primary tumors has
previously been shown to promote proliferation and inva-
sion of metastatic cells. The concurrent expression of
CXCL12 at distant sites including the lungs, liver, brain
and bone marrow suggests a possible homing mechanism
for neoplastic cells to these organ specific sites [9].
Due to cytokine involvement in malignant progression of
the primary tumor and the metastatic process, chemok-
ines might represent a potential therapeutic target for can-
cer patients. Promising animal model data has shown that
inhibiting interactions between CXCL12 and CXCR4 in a
model of murine B16 melanoma cells will impair the met-
astatic process [10].
Growth factor cytokines were also shown to be implicated
into malignant growth of melanoma cells. Hepatocyte
growth factor (HGF) has been previously shown to pro-
mote the migration of uveal melanoma cell lines in vitro
(SOM196B, SOM157d, SOM267, SOM269) [8]. Expres-
sion of HGF in the 5 human uveal melanoma cell lines
(92.1, SP6.5, MKT-BR, OCM-1, UW-1), and the functional
significance of this expression has not yet been elucidated.
The present study was designed in order to analyze the
expression of CXCL12, CXCL8, CXCL1, and HGF in five
human uveal melanoma cell lines (92.1, SP6.5, MKT-BR,
OCM-1, UW-1) and to investigate the effects of these fac-
tors on the migratory ability of the 5 cell lines. Demon-
stration of a functional role for CXCL12, CXCL8, CXCL1,
and HGF in uveal melanoma may yield novel therapeutic
targets. Chemokine receptor inhibitors should be further
investigated in the future, in order to possibly delay or
inhibit tumor growth and metastasis.
Methods
Cell Culture
Five human uveal melanoma cell lines (92.1, SP6.5, MKT-
BR, OCM-1, UW-1) were incubated at 37°C in a humidi-
fied 5% CO2 enriched atmosphere. These cells were cul-
tured with RPMI-1640 medium (Invitrogen),
supplemented with 5% heat inactivated fetal bovine
serum (FBS; Invitrogen), 1% fungizone (Invitrogen), and
1% penicillin-twice weekly, at every media change, for
normal growth by phase contrast microscopy. The cul-
tures were grown to confluence and passaged by treatment
with 0.05% trypsin in EDTA (Corning) at 37°C and
washed in 7 ml RPMI-1640 media before being centri-
fuged at 120 g for 10 minutes to form a pellet.
The uveal melanoma cell lines 92.1, SP6.5, MKT-BR,
OCM-1, and UW-1 had been established by Dr. Jager
(University Hospital Leiden, The Netherlands), Dr. Pelle-
tier (Laval University, Quebec, Canada), Dr. Belkhou (CJF
INSERM, France) and Dr. Albert (University of Wisconsin-
Madision, USA), respectively [11,12].Journal of Carcinogenesis 2007, 6:2 http://www.carcinogenesis.com/content/6/1/2
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Cell Migration Assay
A QCM™ 24-Well Colorimetric Cell Migration Assay
(Chemicon) was used for this experiment. Uveal
melanoma cell lines were trypsinized and seeded at a con-
centration of 1 × 106 cells/ml in serum free RPMI-1640
medium and placed in the upper well insert of a QCM™
24-Well Colorimetric Cell Migration Assay (Chemicon).
Each individual chemokine was reconstituted and diluted
to predetermined, optimum concentrations in serum free
RPMI-1640 medium (CXCL12: 100 ng/ml, CXCL8: 300
ng/ml, CXCL1: 40 ng/ml, HGF: 50 ng/ml) and placed in
the lower chamber of the cell migration assay. All five cell
lines were done in triplicate for each of the selected
chemo-attractants. The 24-Well Plates were then incu-
bated for 24 hours in a humidified 5% enriched CO2
atmosphere. Cells that migrated through the 8 μm pore
membranes, located at the bottom of every well insert,
were stained and eluted. The optical density of the stained
cells was then read by a colorimetric plate reader at 560
nm.
Immunohistochemistry
Cytopsins of the 5 human Uveal Melanoma cell lines were
made using a Cytospin3 machine (Shandon). Cells from
culture were diluted to a concentration of 250,000 cells/
ml, and a 300 μL solution at that concentration was
placed in each spin to be evenly plated on each slide. All
slides were then immunostained with primary anti-
human monoclonal antibodies against CXCL1 (clone
#:20326), CXCL8 (clone #: 6217), and their receptor
CXCR1 (clone #: 42705), and CXCR2 (clone #: 48311)
using a standard Avidin-Biotin Complex method for each
antibody (R&D Systems).
Quantitative real-time PCR
Appropriate primers for CXCL12, CXCL8, CXCL1, and
HGF were chosen, (QuantiTect® Primer Assays) for use
with QuantiTect SYBR® green kits (Qiagen), for this exper-
iment. Total mRNA was then extracted from all 5 human
uveal melanoma cell lines from culture (92.1, SP6.5,
MKT-BR, OCM-1, UW-1) using an RNeasy RNA extraction
kit (Qiagen). A Chromo4 thermocycler (MJ Research) was
used for all experiments and all results were analyzed
using the GeneEx software. Beta actin was used as a house-
keeper gene for purposes of normalization.
Statistical Analysis
Results from the migration assay for each cell line were
directly compared to the negative control using a Stu-
dent's T-test.
Results
Migration Assay
All 5 human uveal melanoma cell lines (92.1, SP6.5,
MKT-BR, OCM-1, UW-1) migrated towards the selected
chemo-attractants at a level greater than the selected neg-
ative control (serum-free RPMI media) (p < 0.05) except
for cell line OCM-1 towards chemokine CXCL1 (p-value =
0.0575). Chemokines CXCL1 and CXCL8 resulted in the
greatest average migration for all five cell lines followed
by CXCL12 and HGF respectively. (Figure 1)
Immunohistochemistry
All 5 human uveal melanoma cell line cytospins stained
positive for CXCL1, CXCL8, and their receptors CXCR2
and CXCR1 respectively. The ligand staining for CXCL1
and CXCL8 showed more of a cytoplasmic stain while the
receptor staining for CXCR1 and CXCR2 showed more
membranous staining when viewed at a magnification of
400×. (Figure 2)
Quantitative Real-Time PCR
All 5 human uveal melanoma cell lines were shown to
produce significant levels of CXCL8, CXCL1, and HGF.
SP6.5 and UW-1 cell lines exhibited the greatest produc-
tion of CXCL1 and CXCL8 followed by 92.1 > OCM-1 >
MKT-BR. None of the 5 cell lines expressed detectable lev-
els of CXCL12. (Figure 3)
Discussion
The prominent site of metastatic disease in uveal
melanoma patients is the liver. Many reasons for this
organ-specificity still remain unknown. Recent studies in
other related cancers have shown that chemokines and
cytokines play an integral role in "guiding" these cells to
organ specific locations. For example, malignant cutane-
ous melanoma and breast carcinoma express chemokine
receptors which may play an important role in determin-
ing the metastatic location of these tumor cells [8]. More
specifically, recent evidence suggests that the CXCR4/
CXCL12 axis plays an integral role in guiding metastatic
cells from breast carcinoma [13].
The five human uveal melanoma cell lines used in this
study have been previously characterized and classified by
their different metastatic and proliferative potential [14].
From this previous study, it was shown that the cell lines
92.1 and SP6.5 were classified as being highly prolifera-
tive and having high metastatic potential relative to the
other three cell lines tested (MKT-BR, OCM-1, UW-1).
In our study, the cell line SP6.5 also expressed the highest
levels of CXCL1 and CXCL8 as measured by real-time PCR
analysis. These chemokines have previously been shown
to stimulate melanoma cellular proliferation [15] and
CXCL1 and CXCL8 were shown to be involved in invasion
and metastasis of melanoma cells [9]. CXCL8 has been
linked to migration of melanoma cells [16] and the induc-
tion of matrix metalloproteinase-2 expression, facilitatingJournal of Carcinogenesis 2007, 6:2 http://www.carcinogenesis.com/content/6/1/2
Page 4 of 6
(page number not for citation purposes)
extracellular matrix degradation and tumor cell migration
[17].
In contrast with the results obtained for SP6.5, the MKT-
BR cell line showed very low levels of expression of
CXCL8, CXCL1, and HGF. This cell line has been previ-
ously characterized as having no metastatic potential in
an animal model [18]. It may be possible that these spe-
cific factors are needed in higher concentration in order to
achieve a higher metastatic potential.
It was previously suggested that CXCL12 expression at dis-
tant sites including the lungs, liver, brain and bone mar-
row may contribute to a possible homing mechanism for
neoplastic cells to these organ-specific sites. In our study,
none of the 5 human uveal melanoma cell lines expressed
any detectable levels of CXCL12. The only known receptor
for CXCL12, CXCR4, was previously shown to be
expressed in different cancers including cutaneous
melanoma, colon cancer, prostate cancer, breast cancer
and neuroblastoma [19]. Unpublished data from our lab-
oratory has also shown that CXCR4 was positive in 31 pri-
mary human uveal melanoma patient samples. It is
possible that CXCR4 positive cells will migrate towards
organs secreting CXCL12 (bone, liver, lung, brain) which
display organ specific homing and metastasis [19]. In
uveal melanoma, the pattern of metastatic spread is pre-
dominantly to the liver, therefore suggesting that CXCL12
expression in the liver may be involved in the homing of
uveal melanoma cells to this site.
Photomicrographies. Cytospins of uveal melanoma cell lines Figure 1
Photomicrographies. Cytospins of uveal melanoma cell lines. (A) UW-1 staining positive for CXCL1 (B) UW-1 stain-
ing positive for CXCR2 (C) 92.1 staining positive for CXCL8 (D) OCM-1 staining positive for CXCR1 (red chromogen, ×400).Journal of Carcinogenesis 2007, 6:2 http://www.carcinogenesis.com/content/6/1/2
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Hepatocyte growth factor (HGF) initiates invasive onco-
genic cellgrowth [20]. HGF initiates internal cellular sign-
aling to the cancer cells, which allows the cells to invade
and metastasize by combining cell proliferation, motility,
morphogenesis, and cell survival [20]. In uveal
melanoma, the epitheliod cells, (the cell type with the
Quantitative real-time PCR graph Figure 3
Quantitative real-time PCR graph. Total mRNA extracted from 5 human uveal melanoma cell lines amplified for CXCL8, 
CXCL1, and HGF primers displaying different relative expression.
Cell migration data for 5 human uveal melanoma cell lines Figure 2
Cell migration data for 5 human uveal melanoma cell lines.Publish with BioMed Central    and   every 
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highest metastatic potential) were shown to express the c-
met receptor for HGF [21]. It is possible that the expres-
sion of HGF by these 5 cell lines does induce the motility
of these c-met positive cells, which can also be homed to
the liver via HGF secretion.
Conclusion
In conclusion, characterizing the expression of CXCL12,
CXCL8, CXCL1, and HGF in uveal melanoma cell lines
leads us to a better understanding of how these cytokines
are integral in the metastatic process. Further characteriza-
tion and understanding of their roles may lead to novel
therapies that target these factors, which may delay or
inhibit the metastatic process.
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